» Articles » PMID: 10477269

Model of 2,3-bisphosphoglycerate Metabolism in the Human Erythrocyte Based on Detailed Enzyme Kinetic Equations: Equations and Parameter Refinement

Overview
Journal Biochem J
Specialty Biochemistry
Date 1999 Sep 8
PMID 10477269
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Over the last 25 years, several mathematical models of erythrocyte metabolism have been developed. Although these models have identified the key features in the regulation and control of erythrocyte metabolism, many important aspects remain unexplained. In particular, none of these models have satisfactorily accounted for 2,3-bisphosphoglycerate (2,3-BPG) metabolism. 2,3-BPG is an important modulator of haemoglobin oxygen affinity, and hence an understanding of the regulation of 2,3-BPG concentration is important for understanding blood oxygen transport. A detailed, comprehensive, and hence realistic mathematical model of erythrocyte metabolism is presented that can explain the regulation and control of 2,3-BPG concentration and turnover. The model is restricted to the core metabolic pathways, namely glycolysis, the 2,3-BPG shunt and the pentose phosphate pathway (PPP), and includes membrane transport of metabolites, the binding of metabolites to haemoglobin and Mg(2+), as well as pH effects on key enzymic reactions and binding processes. The model is necessarily complex, since it is intended to describe the regulation and control of 2,3-BPG metabolism under a wide variety of physiological and experimental conditions. In addition, since H(+) and blood oxygen tension are important external effectors of 2,3-BPG concentration, it was important that the model take into account the large array of kinetic and binding phenomena that result from changes in these effectors. Through an iterative loop of experimental and simulation analysis many values of enzyme-kinetic parameters of the model were refined to yield close conformity between model simulations and 'real' experimental data. This iterative process enabled a single set of parameters to be found which described well the metabolic behaviour of the erythrocyte under a wide variety of conditions.

Citing Articles

Hemoglobin Variants as Targets for Stabilizing Drugs.

Zoldakova M, Novotny M, Khakurel K, Zoldak G Molecules. 2025; 30(2).

PMID: 39860253 PMC: 11767434. DOI: 10.3390/molecules30020385.


Modulation of the Oxygenation State and Intracellular pH of Erythrocytes by Inositol-Trispyrophosphate Investigated by P NMR Study of 2,3-DPG.

Koj S, Niedziela T, Rossowska J, Schmitt J, Lehn J, Nicolau C J Cell Mol Med. 2025; 29(2):e70343.

PMID: 39828634 PMC: 11742965. DOI: 10.1111/jcmm.70343.


It's in your blood: The impact of age, sex, genetic factors and exposures on stored red blood cell metabolism.

DAlessandro A Transfus Apher Sci. 2024; 63(6):104011.

PMID: 39423666 PMC: 11606750. DOI: 10.1016/j.transci.2024.104011.


Biological and genetic determinants of glycolysis: Phosphofructokinase isoforms boost energy status of stored red blood cells and transfusion outcomes.

Nemkov T, Stephenson D, Earley E, Keele G, Hay A, Key A Cell Metab. 2024; 36(9):1979-1997.e13.

PMID: 38964323 PMC: 11374506. DOI: 10.1016/j.cmet.2024.06.007.


The differential regulation of placenta trophoblast bisphosphoglycerate mutase in fetal growth restriction: preclinical study in mice and observational histological study of human placenta.

Stroganov S, Harris T, Fellus-Alyagor L, Ben Moyal L, Plitman Mayo R, Golani O Elife. 2024; 13.

PMID: 38314803 PMC: 10883672. DOI: 10.7554/eLife.82631.


References
1.
Albe K, Butler M, Wright B . Cellular concentrations of enzymes and their substrates. J Theor Biol. 1990; 143(2):163-95. DOI: 10.1016/s0022-5193(05)80266-8. View

2.
Gracy R . Triosephosphate isomerase from human erythrocytes. Methods Enzymol. 1975; 41:442-7. DOI: 10.1016/s0076-6879(75)41096-5. View

3.
Beton , Wang , Mori , Eaves , Main , Foster . Measuring the Probability Density of Quantum Confined States. Phys Rev Lett. 1995; 75(10):1996-1999. DOI: 10.1103/PhysRevLett.75.1996. View

4.
Schneider A, Valentine W, Hattori M, HEINS Jr H . HEREDITARY HEMOLYTIC ANEMIA WITH TRIOSEPHOSPHATE ISOMERASE DEFICIENCY. N Engl J Med. 1965; 272:229-35. DOI: 10.1056/NEJM196502042720503. View

5.
Magnani M, Stocchi V, Ninfali P, Dacha M, FORNAINI G . Action of oxidized and reduced glutathione on rabbit red blood cell hexokinase. Biochim Biophys Acta. 1980; 615(1):113-20. DOI: 10.1016/0005-2744(80)90014-5. View